Meet our members: Katy Tong Tin Fung

We spoke to Katy Tong Tin Fung, Patient Advocate and Patient Engagement Manager of Cancerinformation.com.hk, Hong Kong
 

What led you to work in the field of lung cancer?

My passion for lung cancer advocacy stems from witnessing the struggles of patients and carers. I’ve seen many face uncertainty and insufficient resources, which motivates me to advocate for better support and awareness. I believe contributing to society through education and advocacy can truly make a difference.
 

What does an average work day look like for you?

An average work day for me is a blend of kindness, passion and purpose. I start by connecting with patients and carers, listening to their stories and challenges. I organise workshops and educational programmes to empower them with knowledge. Each day I navigate the realities of life and death, but witnessing the strength and resilience of our community fills me with hope and motivates me to continue this vital work.
 

What is working well in your country, and what could be improved for lung cancer treatment?

In Hong Kong, we have access to advanced lung cancer treatments, yet financial barriers remain a significant concern for many patients. While current policies support treatment advances, there is a pressing need to enhance screening options. We are actively advocating for low-dose computed tomography as a public screening method, aiming to improve early detection and outcomes.
 

What motivated you to join the Network?

We were motivated to join the Network to collaborate with international experts and share insights on effective policies. I believe that by learning from each other, we can strengthen our advocacy efforts. Together, we can make greater strides in improving outcomes.
 

What would you like to see from the Network as it develops?

We would like the Network to foster collaboration among stakeholders, share best practices and develop comprehensive guidelines. This will enhance our collective impact and ultimately improve outcomes.
 

What changes would you like to see in lung cancer care on a global level?

We would like to see increased access to early detection and innovative treatments. Emphasising patient-centred care, we should ensure that treatment plans consider individual needs and preferences. Additionally, fostering global collaboration in research and policy will improve equitable care and reduce the stigma associated with lung cancer.
 

What do you think is the most exciting research finding of the last five years?

The integration of artificial intelligence in genomic profiling. AI enhances the analysis of genomic data, identifying actionable mutations and predicting treatment responses. This paves the way for personalised medicine, promising to improve outcomes and revolutionise lung cancer care.
 

Outside of work, what do you spend your time doing?

Outside of work, I find solace and joy in sailing. Being on the water allows me to connect with nature, helping to clear away negativity and restore balance in my life. I often remind myself, ‘You can’t control the wind, but you can adjust the sails,’ which resonates deeply with our journeys in life. One of my cherished programmes involves taking cancer patients sailing; we create lasting memories together. These experiences not only uplift our spirits but also strengthen our bonds, reminding us that, despite challenges, we can navigate life’s waters with hope and determination.

The Lung Cancer Policy Network brings together a unique mix of experts in lung cancer from around the world, united in their passion to eliminate lung cancer as a cause of death.

We regularly share profiles of our members so that you can find out more about what led them to work in lung cancer and what changes they would like to see in lung cancer prevention and care on a global level.